Navigation Links
Pharma Companies Tie Up To Develop Bird Flu Vaccine

US based Novavax and India based Bharat Biotech International, two major pharma companies, agreed to work together for developing the vaccine for bird flu that will cater to the needs of Indian and Southeast Asian markets. //

Under the agreement, Bharat Biotech will fund all pre-clinical and clinical development work with Novavax and be responsible for the commercialisation of the single dose vaccine. In return, Novavax will receive unrestricted access to all pre-clinical and clinical data and a royalty on sales.

Rahul Singhvi, president and CEO of Novavax, said that Novavax would use its Virus Like Particle (VLP) technology to develop the vaccine. VLP uses recombinant protein to imitate the structure of a virus to provide protection without the risk of infection or disease, he told a news conference.

The Nasdaq-listed Novavax has already completed the VLP trials in mice and now plans to undertake the human trials through Bharat Biotech.

"Bharat Biotech has chosen Novavox to develop, produce and distribute a vaccine against H5N1 and other strains of avian influenza for the Indian population," Singhvi said.

"There are 16 HA (haemagluttinin) and NA (neuraminidase) sub-types of influenza viruses which are known to infect poultry. A combination of these sub-types could begin infecting human populations," said Krishna M. Ella, founder of Bharat Biotech.

Pointing out that pandemic influenza had killed 100 million people in 1918, he warned that a pandemic now could result in the death of 175 to 300 million people all over the world.

The alliance between the two companies will be overseen by a steering committee chaired by Richard Klausner, eminent scientist, former executive director of the Bill and Melinda Gates Foundation and former director of the US National Cancer Institute.

"The World Bank estimates that pandemic flu could cost the global economy $1 trillion. We are not creating a panic b ut we should be prepared to deal with a pandemic," said Klausner, who is also a special advisor to the government of India and Novavax Inc.

M.K. Bhan, secretary, department of biotechnology, is on the steering committee. The department will provide enabling support to the alliance.

Headquartered in Malvern, Pennsylvania, Novavax is a speciality biopharmaceutical company engaged in the research, development and commercialisation of proprietary products.

Located in Genome Valley near Hyderabad, Bharat Biotech is a multidimensional biotechnology company specialising in product-oriented research, development and manufacturing of vaccines and bio therapeutics.

India has reported cases of avian flu among chickens in Maharastra and Gujarat states, leading to the culling of thousands of chicken around the affected areas.

--Edited IANS
'"/>




Related medicine news :

1. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Pharma cos must forge Strategic alliances
4. Medicis Pharmaceutical company enters pediatric market
5. Pharma majors gear to supply anti-anthrax drug
6. Pharmacies in for a dose of bitter medicine
7. Andhra Pradesh to set up Pharma City
8. Sun Pharma to launch chiral version of omeprazole soon
9. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
10. Pharmacia may take 51.5 percent Abbott stake
11. Pharmaceutical companies are targeting patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... , ... An April 24th article on Yahoo! Beauty discusses the case of Jessica ... a weight loss surgery. The woman, declaring “I will not hate my body anymore!” posted ... dramatic weight loss. Dr. Feiz & Associates notes that, while it often refers its patients ...
(Date:4/28/2017)... ... April 28, 2017 , ... Accreditation Commission for ... Care Association of America (HCAOA). This agreement allows HCAOA members to receive special ... as discounts on Accreditation University (AU) educational resources that help prepare HCAOA members ...
(Date:4/28/2017)... ... April 28, 2017 , ... Somnoware, ... of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to create and edit their ... reporting process and provides a familiar interface that does not require additional training ...
(Date:4/28/2017)... ... 2017 , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced ... its outlook as “stable.” At the same time, the ratings agency cautioned that the ... dip below “capital adequacy” thresholds required for its strong rating. , “Horizon is committed ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. ... GlycoMark test throughout the Northeast U.S. , GlycoMark is the only clinically ... GlycoMark test provides a clinically proven one- to two-week measure of hyperglycemic excursions, ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 NeuroVive ... ("NeuroVive") today announced positive preclinical results demonstrating ... compound for non-alcoholic steatohepatitis (NASH), in an ... NV556 has previously shown similar ... model. Today, NeuroVive,s scientists present novel data ...
(Date:4/19/2017)... April 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) ... & Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in ... , Chief Executive Officer of the Company is scheduled to present ... Richard Bear and the Chairman of the Board, Tony ... ...
(Date:4/19/2017)... April 19, 2017 The Mobile X-Ray product segment ... healthy CAGR during the forecast period Mobile X-Ray ... global digital mobile X-Ray devices market, which is estimated to ... expanding at a CAGR of 7% over the forecast period. ... of more than US$ 100 Mn in 2017 over 2016. ...
Breaking Medicine Technology: